Asian Study to Investigate Safety and Efficacy of Optimized Dosing of Advagraf in Kidney Transplantation
Clinical trial NCT02161237 · COMPLETED
Trial details
- NCT number
- NCT02161237
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-26
- Primary completion
- 2016-12-22
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.